首页 > 最新文献

Journal of Ayurveda and Integrated Medical Sciences (JAIMS)最新文献

英文 中文
Physico-chemical Analysis of beeswax procured from Mumbai market, Western Ghats (Natural Habitat) 西高止山脉(自然栖息地)孟买市场蜂蜡的理化分析
Pub Date : 2020-10-25 DOI: 10.21760/jaims.5.5.26
Shruti Naik, Sheela Pargunde
Beeswax is the substance that is obtained from the structure of a honey comb. The bees secrete wax to build the honey combs to store honey. It has rich hydrophobic property, the beeswax is in fact present within cosmetics and body products. Also, beeswax is used in food industry. Beeswax is a complex mixture of hydrocarbons, free fatty acid, esters of fatty acid. Beeswax plays an important role in Ayurvedic medicine, the traditional medicine name with Madhushistha (Beewax). The Madhushistha is used for the care of wound from abrasion or even from burns with topical application. Some references in Ayurvedic granth highlight the use of Madhushistha in combination with other herbal and mineral mixture, like Sikta Taila, Mruddaharshringa, Jatyadi Taila, etc. Beeswax is mainly of two types, natural beeswax and processed beeswax. Natural beeswax is clarified further heating in water with petroleum waxes. Because of high demand and shortage in market, adulteration of beeswax with cheaper materials are common like animal fat, plant oil and petroleum spirits (Paraffin wax). Hence authenticity of beeswax is major concern and that can be determined by using physico-chemical parameters such as- organoleptic test, solubility, Melting point, Spacific gravity, Refractive index, Acid value, Ester value, Saponification value, volatile matter. With this justification the present study is expected to determine the quality status of four different beeswax samples procured from Mumbai market, western ghats (Natural habitat). The physico-chemical analysis revealed that volatile matter is detected in market sample (2) whereas market sample (1) shows higher melting point as compare to beeswax collected from the Natural habitat. Market sample (1,2) of beeswax shows slight adulteration hence natural habitat samples (1,2) of beeswax should be used in medicine preparation.
蜂蜡是从蜂巢的结构中获得的物质。蜜蜂分泌蜂蜡来建造蜂巢来储存蜂蜜。它具有丰富的疏水性,蜂蜡实际上存在于化妆品和身体产品中。此外,蜂蜡还用于食品工业。蜂蜡是碳氢化合物、游离脂肪酸、脂肪酸酯的复杂混合物。蜂蜡在阿育吠陀医学中扮演着重要的角色,传统的医学名称是Madhushistha(蜂蜡)。该Madhushistha是用于护理伤口擦伤,甚至烧伤与局部应用。阿育吠陀文献中的一些文献强调了Madhushistha与其他草药和矿物混合物的结合使用,如Sikta Taila, Mruddaharshringa, Jatyadi Taila等。蜂蜡主要有天然蜂蜡和加工蜂蜡两种。天然蜂蜡是用石油蜡在水中进一步加热澄清的。由于蜂蜡需求量大,市场供应不足,在蜂蜡中掺入动物脂肪、植物油和石油精(石蜡)等廉价原料是很常见的。因此,蜂蜡的真实性是主要关注的问题,可以通过使用物理化学参数来确定,如感官测试,溶解度,熔点,太平洋重力,折射率,酸值,酯值,皂化值,挥发物。有了这个理由,本研究预计将确定从西高止山脉(自然栖息地)孟买市场采购的四种不同蜂蜡样品的质量状况。理化分析表明,市场样品(2)中检测到挥发性物质,而市场样品(1)的熔点高于从自然栖息地收集的蜂蜡。蜂蜡的市场样品(1,2)显示有轻微掺假,因此应使用自然生境样品(1,2)的蜂蜡进行药物配制。
{"title":"Physico-chemical Analysis of beeswax procured from Mumbai market, Western Ghats (Natural Habitat)","authors":"Shruti Naik, Sheela Pargunde","doi":"10.21760/jaims.5.5.26","DOIUrl":"https://doi.org/10.21760/jaims.5.5.26","url":null,"abstract":"Beeswax is the substance that is obtained from the structure of a honey comb. The bees secrete wax to build the honey combs to store honey. It has rich hydrophobic property, the beeswax is in fact present within cosmetics and body products. Also, beeswax is used in food industry. Beeswax is a complex mixture of hydrocarbons, free fatty acid, esters of fatty acid. Beeswax plays an important role in Ayurvedic medicine, the traditional medicine name with Madhushistha (Beewax). The Madhushistha is used for the care of wound from abrasion or even from burns with topical application. Some references in Ayurvedic granth highlight the use of Madhushistha in combination with other herbal and mineral mixture, like Sikta Taila, Mruddaharshringa, Jatyadi Taila, etc. Beeswax is mainly of two types, natural beeswax and processed beeswax. Natural beeswax is clarified further heating in water with petroleum waxes. Because of high demand and shortage in market, adulteration of beeswax with cheaper materials are common like animal fat, plant oil and petroleum spirits (Paraffin wax). Hence authenticity of beeswax is major concern and that can be determined by using physico-chemical parameters such as- organoleptic test, solubility, Melting point, Spacific gravity, Refractive index, Acid value, Ester value, Saponification value, volatile matter. With this justification the present study is expected to determine the quality status of four different beeswax samples procured from Mumbai market, western ghats (Natural habitat). The physico-chemical analysis revealed that volatile matter is detected in market sample (2) whereas market sample (1) shows higher melting point as compare to beeswax collected from the Natural habitat. Market sample (1,2) of beeswax shows slight adulteration hence natural habitat samples (1,2) of beeswax should be used in medicine preparation.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123547142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Virechana Karma along with Guggulu Kalpanas in the management of Medoroga - A Double Arm Study Virechana Karma和Guggulu Kalpanas在治疗梅多罗加中的作用——一项双臂研究
Pub Date : 2020-10-25 DOI: 10.21760/jaims.5.5.11
Pooja Abhrange, S. G. Chavan, A. Prashanth
Metabolism is the natural process of the body, which is necessary to maintenance of the homeostasis of an individual person. Everybody constitutions are always in the process of metabolism, which is a combination of Anabolism (Construction) and Catabolism (Deterioration). As Agni is prime factor for all the Chayapachayakriya. Medoroga, is one of the Metabolic disease, in which contributing factors are Agni, Ama along with Kaphapradhana Tridosha, Medodhathu. Due to various types of etiological factors, the Agni in the body gets vitiated and Jatharagnimandya occurs. By this Jatharagnimandya, Dhathuparinama will not occur properly. This will lead to Medoroga and further many other Upadravas. To correct these conditions, Ayurveda has many modes of therapies like Samshodhana, Samshamana. By these we can correct the metabolism from the root cause. Here 40 Subjects diagnosed with Medoroga w.s.r. to Hyperlipidemia fulfilling the Inclusion criteria were selected for study and randomly categorized into two groups as Group A and Group B each consisting of 20 subjects. For both groups Amapachana with Chitrakadi Vati, Sadhyosnehapana with Murchita Sarshapa Taila, Sarvanga Abhyanga with Murchita Tila Taila followed by Swedana. And Virechana was administered with Virechana Gulika. Than each group received two different Shamanoushadhi. So, the objective of the study is to establish the efficacy of Virechana along with Dashanga Guggulu and Virechana along with Shadushana Guggulu in the management of Medoroga.
新陈代谢是身体的自然过程,是维持个体体内平衡所必需的。每个人的身体都处于新陈代谢的过程中,这是合成代谢(构建)和分解代谢(分解)的结合。因为烈火是所有《Chayapachayakriya》的主要因素。Medoroga是一种代谢性疾病,其中的促成因素是Agni, Ama以及Kaphapradhana Tridosha, medohathu。由于各种各样的病因,体内的烈火被破坏,出现了Jatharagnimandya。通过这个Jatharagnimandya, Dhathuparinama将不会正确地发生。这将导致梅多罗加和进一步的许多其他的Upadravas。为了纠正这些情况,阿育吠陀有许多模式的治疗,比如散散禅,散散禅。通过这些,我们可以从根源上纠正新陈代谢。本研究选取40例符合纳入标准的Medoroga w.s.r.至高脂血症患者作为研究对象,随机分为A组和B组,每组20例。在这两个群体中,Amapachana和Chitrakadi Vati, Sadhyosnehapana和Murchita Sarshapa Taila, Sarvanga Abhyanga和Murchita Tila Taila,其次是Swedana。Virechana和Virechana Gulika一起使用。然后每组接受两个不同的Shamanoushadhi。因此,本研究的目的是确定Virechana和Dashanga guguulu以及Virechana和Shadushana guguulu在治疗梅多罗加中的疗效。
{"title":"Effect of Virechana Karma along with Guggulu Kalpanas in the management of Medoroga - A Double Arm Study","authors":"Pooja Abhrange, S. G. Chavan, A. Prashanth","doi":"10.21760/jaims.5.5.11","DOIUrl":"https://doi.org/10.21760/jaims.5.5.11","url":null,"abstract":"Metabolism is the natural process of the body, which is necessary to maintenance of the homeostasis of an individual person. Everybody constitutions are always in the process of metabolism, which is a combination of Anabolism (Construction) and Catabolism (Deterioration). As Agni is prime factor for all the Chayapachayakriya. Medoroga, is one of the Metabolic disease, in which contributing factors are Agni, Ama along with Kaphapradhana Tridosha, Medodhathu. Due to various types of etiological factors, the Agni in the body gets vitiated and Jatharagnimandya occurs. By this Jatharagnimandya, Dhathuparinama will not occur properly. This will lead to Medoroga and further many other Upadravas. To correct these conditions, Ayurveda has many modes of therapies like Samshodhana, Samshamana. By these we can correct the metabolism from the root cause. Here 40 Subjects diagnosed with Medoroga w.s.r. to Hyperlipidemia fulfilling the Inclusion criteria were selected for study and randomly categorized into two groups as Group A and Group B each consisting of 20 subjects. For both groups Amapachana with Chitrakadi Vati, Sadhyosnehapana with Murchita Sarshapa Taila, Sarvanga Abhyanga with Murchita Tila Taila followed by Swedana. And Virechana was administered with Virechana Gulika. Than each group received two different Shamanoushadhi. So, the objective of the study is to establish the efficacy of Virechana along with Dashanga Guggulu and Virechana along with Shadushana Guggulu in the management of Medoroga.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126400247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacognostical, phytochemical and HPTLC evaluation of Erandamuladi Kwatha Churna - A polyherbal formulation for pharmaceutical standardization 中药标准化复方桂花兰的生药学、植物化学及HPTLC评价
Pub Date : 2020-10-25 DOI: 10.21760/jaims.5.5.27
S. N, A. Thakar, Harisha C.R., V. Shukla
Introduction: Erandamuladi Kwatha is mentioned in Ayurveda classics as a therapeutic formulation of Basti mainly to treat Trika-prishta Shoola (low back ache). The most common disorder which affects the movement of leg particularly in the productive period of life is low backache. Erandamuladi Kwatha used in Basti contains 15 drugs in which most of the drugs are having Ushna Veerya and are Vatakaphahara in nature. Materials and Methods: Yavakuta Choorna of Erandamuladi Kwatha was evaluated for their pharmacognostic and pharmaceutical analysis. Results and Discussion: Pharmacognostic study showed the presence of contents such as starch grains of Kantakari, rosette crystal of Rasna, pollen grain of Atibala etc. Physico-chemical analysis showed that the loss on drying 7.74%, Ash value 6.78%, Water soluble extract 20.12%, Alcohol soluble extract 4.3%, pH 7.2. Conclusion: From the study, data developed can be espoused for laying down the standards of Erandamuladi Kwatha.
简介:Erandamuladi Kwatha在阿育吠陀经典中被提到作为basi的治疗配方,主要用于治疗Trika-prishta Shoola(腰痛)。影响腿部运动的最常见的疾病是腰痛,特别是在生活的生产时期。在Basti中使用的Erandamuladi Kwatha含有15种药物,其中大多数药物具有Ushna Veerya和Vatakaphahara性质。材料与方法:采用生药学评价和药理分析方法,对枇杷草进行了药理评价。结果与讨论:生药学研究表明,该药材中含有卡塔卡丽淀粉粒、拉斯纳莲座晶、天麻花粉粒等成分。理化分析表明:干燥损失7.74%,灰分值6.78%,水溶性浸出物20.12%,醇溶浸出物4.3%,pH值7.2。结论:本研究提供的数据可用于制定标准。
{"title":"Pharmacognostical, phytochemical and HPTLC evaluation of Erandamuladi Kwatha Churna - A polyherbal formulation for pharmaceutical standardization","authors":"S. N, A. Thakar, Harisha C.R., V. Shukla","doi":"10.21760/jaims.5.5.27","DOIUrl":"https://doi.org/10.21760/jaims.5.5.27","url":null,"abstract":"Introduction: Erandamuladi Kwatha is mentioned in Ayurveda classics as a therapeutic formulation of Basti mainly to treat Trika-prishta Shoola (low back ache). The most common disorder which affects the movement of leg particularly in the productive period of life is low backache. Erandamuladi Kwatha used in Basti contains 15 drugs in which most of the drugs are having Ushna Veerya and are Vatakaphahara in nature. Materials and Methods: Yavakuta Choorna of Erandamuladi Kwatha was evaluated for their pharmacognostic and pharmaceutical analysis. Results and Discussion: Pharmacognostic study showed the presence of contents such as starch grains of Kantakari, rosette crystal of Rasna, pollen grain of Atibala etc. Physico-chemical analysis showed that the loss on drying 7.74%, Ash value 6.78%, Water soluble extract 20.12%, Alcohol soluble extract 4.3%, pH 7.2. Conclusion: From the study, data developed can be espoused for laying down the standards of Erandamuladi Kwatha.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"143 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122141135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical study on Sandhigata Vata w.r.s. to Osteoarthritis and its management by comparing the efficacy of Samananga Sneha and Samananga Sneha with Shadanga Guggulu 通过比较沙曼甘散、沙曼甘散与沙丹甘谷谷露治疗骨关节炎的疗效,研究沙曼甘散治疗骨关节炎的临床疗效
Pub Date : 2020-10-25 DOI: 10.21760/jaims.5.5.1
Kavitha Cm, Veena Gd
Sandhigata Vata is a disease seen commonly both in developing and developed countries. The disease causes mild, moderate or severe degree of morbidity and rarely mortality. The occurrence of problems is increasingly prevalent now a day due to change in lifestyle, food habits and social and cultural changes as well as travelling. Sandhishula, Sandhishotha, Sandhigraha and Atopa are the important clinical features of Sandhigata Vata. According to WHO, Osteoarthritis is the 2nd commonest problem in the world population i.e. 30%. The major risk factors associated with Kneejoint Osteoarthritis are Age, female sex, obesity, occupational Knee bending. Osteoarthritis is the most common articular disorder that begins asymptomatically and is extremely common by age 70. Almost all people by the age 40 have some pathologic change in weight bearing joints. 25% females and 16% males have symptomatic OA. To study the efficacy of Shamananga Sneha in Sandhigata Vata w.s.r. to Osteoarthritis knee. To compare (study) the efficacy of Shamananga Sneha with Shadanga Guggulu in Janu Sandhigata Vata. To compare the results of the two clinical groups. The study was comparative trial and 30 patients with Janu Sandhigata Vata. All the patients were randomly assigned into two groups namely A and B. Group A receive Shamananga Sneha (Guggulu Tiktaka Ghrita) for 30 days, and Group B receive Shamananga Sneha (Guggulu Tiktaka Ghrita) along with Shadanga Guggulu for 30 days. The patients were clinically evaluated and observations were recorded as in the case performa. Shamananga Sneha (Guggulu Tiktaka Ghrita) along with Shadanga Guggulu i.e. group B was more beneficial in relieving the symptoms than Shamananga Sneha i.e. group A (Guggulu Tiktaka Ghrita).
骨髓瘤是一种在发展中国家和发达国家都很常见的疾病。该病可引起轻度、中度或重度发病,很少死亡。由于生活方式的改变,饮食习惯和社会文化的变化以及旅行,问题的发生越来越普遍。Sandhishula、Sandhishotha、Sandhigraha和Atopa是Sandhigata Vata的重要临床特征。根据世界卫生组织,骨关节炎是世界人口中第二大常见问题,占30%。与膝关节骨关节炎相关的主要危险因素是年龄、女性、肥胖、职业性膝关节弯曲。骨关节炎是最常见的关节疾病,开始时无症状,在70岁时极为常见。几乎所有到40岁的人在负重关节上都有一些病理变化。25%的女性和16%的男性有症状性OA。目的:研究沙曼南散对膝关节骨性关节炎的治疗作用。比较沙曼加散散与沙丹加古古鲁在《山珍山珍》中的疗效。比较两组临床结果。该研究是一项比较试验,对30例Janu Sandhigata Vata患者进行了研究。所有患者随机分为A组和B组,A组服用沙曼南加Sneha (Guggulu Tiktaka Ghrita) 30天,B组服用沙曼南加Sneha (Guggulu Tiktaka Ghrita)和Shadanga Guggulu 30天。对患者进行临床评估,并将观察结果记录为病例表现。Shamananga Sneha (Guggulu Tiktaka Ghrita)和Shadanga Guggulu即B组在缓解症状方面比Shamananga Sneha即A组(Guggulu Tiktaka Ghrita)更有益。
{"title":"Clinical study on Sandhigata Vata w.r.s. to Osteoarthritis and its management by comparing the efficacy of Samananga Sneha and Samananga Sneha with Shadanga Guggulu","authors":"Kavitha Cm, Veena Gd","doi":"10.21760/jaims.5.5.1","DOIUrl":"https://doi.org/10.21760/jaims.5.5.1","url":null,"abstract":"Sandhigata Vata is a disease seen commonly both in developing and developed countries. The disease causes mild, moderate or severe degree of morbidity and rarely mortality. The occurrence of problems is increasingly prevalent now a day due to change in lifestyle, food habits and social and cultural changes as well as travelling. Sandhishula, Sandhishotha, Sandhigraha and Atopa are the important clinical features of Sandhigata Vata. According to WHO, Osteoarthritis is the 2nd commonest problem in the world population i.e. 30%. The major risk factors associated with Kneejoint Osteoarthritis are Age, female sex, obesity, occupational Knee bending. Osteoarthritis is the most common articular disorder that begins asymptomatically and is extremely common by age 70. Almost all people by the age 40 have some pathologic change in weight bearing joints. 25% females and 16% males have symptomatic OA. To study the efficacy of Shamananga Sneha in Sandhigata Vata w.s.r. to Osteoarthritis knee. To compare (study) the efficacy of Shamananga Sneha with Shadanga Guggulu in Janu Sandhigata Vata. To compare the results of the two clinical groups. The study was comparative trial and 30 patients with Janu Sandhigata Vata. All the patients were randomly assigned into two groups namely A and B. Group A receive Shamananga Sneha (Guggulu Tiktaka Ghrita) for 30 days, and Group B receive Shamananga Sneha (Guggulu Tiktaka Ghrita) along with Shadanga Guggulu for 30 days. The patients were clinically evaluated and observations were recorded as in the case performa. Shamananga Sneha (Guggulu Tiktaka Ghrita) along with Shadanga Guggulu i.e. group B was more beneficial in relieving the symptoms than Shamananga Sneha i.e. group A (Guggulu Tiktaka Ghrita).","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130142647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phyto-pharmacognostic evaluation and HPLC study on Sariva (Hemidsmus indicus R.Br) Root 黄麻根植物生药学评价及高效液相色谱研究
Pub Date : 2020-10-25 DOI: 10.21760/jaims.5.5.23
K. Kała, Veena Ms, Prabhavathi
Plants are among the richest sources of bioactive compounds throughout the world for thousands of years and continue to provide new remedies to mankind. Roots of Hemidesmus indicus R. Br. is an important plant drug which is used to cure leprosy, leucoderma, itching, skin disease, asthma, bronchitis, leucorrhoea, dysentery, piles, syphilis, paralysis, urinary disorders and diabetes mellitus. As per Acharya Charaka has mentioned suitable season for collection of Moola i.e. Greeshma and Shishira Rutu. Here an attempt to study to check the potency of root collected as per classical reference. The present study focused on the pharmacognostical, phytochemical investigation as well as HPLC study were performed by taking different solvent extracts of Hemidesmus indicus root. This study highlights the detailed HPLC study on Hemidesmus indicus root by taking different solvent extracts with their increasing polarity which is a referential information for identification parameters and improves our confidence level of acceptability of herbal drugs.
几千年来,植物是世界上最丰富的生物活性化合物来源之一,并继续为人类提供新的治疗方法。赤豆的根。是一种重要的植物药物,用于治疗麻风病、白皮病、瘙痒、皮肤病、哮喘、支气管炎、白带、痢疾、痔疮、梅毒、麻痹、泌尿系统疾病和糖尿病。根据Acharya Charaka提到的适合收集Moola的季节,即Greeshma和Shishira Rutu。本文试图对根据经典文献采集的根的效力进行检验。采用不同溶剂提取液对半边菜根进行了生药学、植物化学和高效液相色谱研究。本研究通过不同溶剂提取液极性递增的方法,对半芒草根进行了详细的高效液相色谱研究,为鉴定参数提供了参考信息,提高了中药可接受度的置信水平。
{"title":"Phyto-pharmacognostic evaluation and HPLC study on Sariva (Hemidsmus indicus R.Br) Root","authors":"K. Kała, Veena Ms, Prabhavathi","doi":"10.21760/jaims.5.5.23","DOIUrl":"https://doi.org/10.21760/jaims.5.5.23","url":null,"abstract":"Plants are among the richest sources of bioactive compounds throughout the world for thousands of years and continue to provide new remedies to mankind. Roots of Hemidesmus indicus R. Br. is an important plant drug which is used to cure leprosy, leucoderma, itching, skin disease, asthma, bronchitis, leucorrhoea, dysentery, piles, syphilis, paralysis, urinary disorders and diabetes mellitus. As per Acharya Charaka has mentioned suitable season for collection of Moola i.e. Greeshma and Shishira Rutu. Here an attempt to study to check the potency of root collected as per classical reference. The present study focused on the pharmacognostical, phytochemical investigation as well as HPLC study were performed by taking different solvent extracts of Hemidesmus indicus root. This study highlights the detailed HPLC study on Hemidesmus indicus root by taking different solvent extracts with their increasing polarity which is a referential information for identification parameters and improves our confidence level of acceptability of herbal drugs.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"127 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131361194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical study to evaluate the effectiveness of Narikela Lavana, Navasadara Yuktha Yavakshara in comparision with Surya and Navasadara Paneeya Kshara in the management of Cholelithiasis 临床研究评价Narikela Lavana、Navasadara Yuktha Yavakshara与Surya、Navasadara Paneeya Kshara治疗胆石症的疗效
Pub Date : 2020-10-25 DOI: 10.21760/jaims.5.5.5
N. ., Srinivas Masalekar
Cholelithiasis is a crystalline concretion formed within the gall bladder by accretion of bile components. Cholelithiasis can be considered as Pittashaya Ashmari, but there is no direct reference of this condition available in Ayurveda. In Ayurveda the effective treatment is Paneeya Kshara. Surya and Navasadara Paneeya Kshara is standard one and which is highly effective treatment in the management of Cholelithiasis but, persisting pain, presence of calculi has limited in its use. To overcome the lacunas present study has been carried out. This study was conducted at SJIIM Hospital Bengaluru and total of 40 patients were randomly allotted into two groups namely Group A with trial drug i.e. 2grams each of Narikela Lavana, Navasadara, Yava Kshara orally with Jala once daily in empty stomach in the morning, every day for 28 days and Group B with control drug i.e. 2grams of Surya and Navasadara Paneeya Kshara orally with Narikela Jala once daily in empty stomach in the morning, every day for 28 days. Assessment was made on Subjective and Objective parameters. Observations were made before the treatment and on 15th day and 30th day to know the efficacy of the treatment. The combination of Narikela Lavana, Navasadara Yuktha Yava Kshara showed a positive result.
胆石症是胆囊内胆汁成分积聚而形成的结晶性结块。胆石症可以被认为是Pittashaya Ashmari,但在阿育吠陀中没有直接参考这种情况。在阿育吠陀,有效的治疗方法是Paneeya Kshara。Surya和Navasadara Paneeya Kshara是标准的,是治疗胆石症的有效方法,但持续疼痛,结石的存在限制了其使用。为了克服这一缺陷,开展了本研究。这项研究是由SJIIM医院班加罗尔,共有40个病人被随机分配到两组即组与试验药物即2克每个Narikela Lavana, Navasadara, Yava Kshara口头与比特杰拉每天一次在早晨空腹,每天28天,B组控制药物即2克萨和Navasadara Paneeya Kshara口头与Narikela比特杰拉曾经每天在早晨空腹,每天为28天。从主客观两方面进行评价。分别于治疗前、第15天、第30天进行观察,了解治疗效果。Narikela Lavana, Navasadara Yuktha Yava Kshara的组合显示出阳性结果。
{"title":"Clinical study to evaluate the effectiveness of Narikela Lavana, Navasadara Yuktha Yavakshara in comparision with Surya and Navasadara Paneeya Kshara in the management of Cholelithiasis","authors":"N. ., Srinivas Masalekar","doi":"10.21760/jaims.5.5.5","DOIUrl":"https://doi.org/10.21760/jaims.5.5.5","url":null,"abstract":"Cholelithiasis is a crystalline concretion formed within the gall bladder by accretion of bile components. Cholelithiasis can be considered as Pittashaya Ashmari, but there is no direct reference of this condition available in Ayurveda. In Ayurveda the effective treatment is Paneeya Kshara. Surya and Navasadara Paneeya Kshara is standard one and which is highly effective treatment in the management of Cholelithiasis but, persisting pain, presence of calculi has limited in its use. To overcome the lacunas present study has been carried out. This study was conducted at SJIIM Hospital Bengaluru and total of 40 patients were randomly allotted into two groups namely Group A with trial drug i.e. 2grams each of Narikela Lavana, Navasadara, Yava Kshara orally with Jala once daily in empty stomach in the morning, every day for 28 days and Group B with control drug i.e. 2grams of Surya and Navasadara Paneeya Kshara orally with Narikela Jala once daily in empty stomach in the morning, every day for 28 days. Assessment was made on Subjective and Objective parameters. Observations were made before the treatment and on 15th day and 30th day to know the efficacy of the treatment. The combination of Narikela Lavana, Navasadara Yuktha Yava Kshara showed a positive result.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"96 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116580755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phyto Pharmacognostic Study of Lagerstroemia speciosa - An Analytical Study 大紫薇植物生药学研究——一种分析研究
Pub Date : 2020-10-25 DOI: 10.21760/jaims.5.5.29
J. S. Murthy, B. Lalitha, Aahalya Sharma
Lagerstroemia speciosa (L.) Pers (Hindi - Jarul, Taglog - Banaba) a member of Lythraceae family is found all over India, specially in Bengal, Assam and Deccan Peninsula. The leaves of L. speciosa is widely used for lowering blood sugar levels in Philippines, Japan and Taiwan. Pharmacognostical investigation of leaves of L. speciosa was done by evaluating its morphological, microscopical studies, Physicochemical and phytochemical parameters. Rasa Nirdharana was done. Microscopical study revealed presence of epidermal cells contained clusters of rosette aggregate calcium oxalate crystals and few cells were mucilaginous. Lower epidermis showed the presence of anomocytic stomata. Physical constants of leaf powder showed, loss on drying - 3.8%, total ash - 6.7%, acid insoluble ash - 1.039%, water soluble extractive value - 8.88%, alcohol soluble extractive value - 4.49% and pH - 5.75. Preliminary phytochemical study revealed the presence of alkaloids, flavonoids, saponins, triterpenes, tannins, proteins and iron. Rasa Nirdharana confirmed the leaves are Kashaya in Rasa. The Pharmacognostical study was useful for authentication of leaves of Lagerstoemia speciosa.
紫薇(Lagerstroemia speciosa)石竹属石竹科的一员,分布在印度各地,特别是在孟加拉、阿萨姆和德干半岛。在菲律宾、日本和台湾,白桦的叶子被广泛用于降低血糖水平。通过形态、显微、理化、植物化学等方面的研究,对白桦叶片进行了生药学研究。Rasa Nirdharana结束了。显微镜下观察发现表皮细胞含有簇状的玫瑰花状草酸钙晶体,少数细胞呈黏液状。下表皮有不规则气孔。叶粉的物理常数为:干燥损失3.8%,总灰分6.7%,酸不溶灰分1.039%,水溶性萃取值8.88%,醇溶萃取值4.49%,pH值5.75。初步的植物化学研究发现其含有生物碱、类黄酮、皂苷、三萜、单宁、蛋白质和铁。Rasa Nirdharana确认这些叶子是Rasa中的Kashaya。本研究对紫花Lagerstoemia speciosa叶片的生药学鉴定有一定的指导意义。
{"title":"Phyto Pharmacognostic Study of Lagerstroemia speciosa - An Analytical Study","authors":"J. S. Murthy, B. Lalitha, Aahalya Sharma","doi":"10.21760/jaims.5.5.29","DOIUrl":"https://doi.org/10.21760/jaims.5.5.29","url":null,"abstract":"Lagerstroemia speciosa (L.) Pers (Hindi - Jarul, Taglog - Banaba) a member of Lythraceae family is found all over India, specially in Bengal, Assam and Deccan Peninsula. The leaves of L. speciosa is widely used for lowering blood sugar levels in Philippines, Japan and Taiwan. Pharmacognostical investigation of leaves of L. speciosa was done by evaluating its morphological, microscopical studies, Physicochemical and phytochemical parameters. Rasa Nirdharana was done. Microscopical study revealed presence of epidermal cells contained clusters of rosette aggregate calcium oxalate crystals and few cells were mucilaginous. Lower epidermis showed the presence of anomocytic stomata. Physical constants of leaf powder showed, loss on drying - 3.8%, total ash - 6.7%, acid insoluble ash - 1.039%, water soluble extractive value - 8.88%, alcohol soluble extractive value - 4.49% and pH - 5.75. Preliminary phytochemical study revealed the presence of alkaloids, flavonoids, saponins, triterpenes, tannins, proteins and iron. Rasa Nirdharana confirmed the leaves are Kashaya in Rasa. The Pharmacognostical study was useful for authentication of leaves of Lagerstoemia speciosa.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115534515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of structural changes observed in Prishtavamsha Sandhigatha Vata (osteoarthritis of vertebral column) 脊柱骨性关节炎的结构变化分析
Pub Date : 2020-10-25 DOI: 10.21760/jaims.5.5.18
Anju Subhash, K. N.
Prishtavamsha Sandhi (joints of vertebral column) is the Cheshtavantha Prathara (movable and floating) type of joint. Twenty four joints are present in Prishtavamsha (vertebral column). Intervertebral joints are the joints which connect vertebrae to each other consists of cartilaginous joints in between the vertebral bodies and synovial joint between vertebral arches. Sandhigatha Vata (osteo arthritis) is one among the Vatavyadhi, which can affect all joints in the body. Sandhigatha Vata (osteoarthritis) will be dominated with symptoms like pain, swelling and impairment of function. In Sandhigatha Vata (osteoarthritis), destruction occurs in the joints due to aggrevated Vata. But it is not clear about the type of destruction observed in the joints. To rule out the various structural changes observed in the joints of Prishtavamsha (vertebral column) this work is being undertaken. Among 100 patients suffering from Prishtavamsha Sandhigatha Vata (osteoarthritis of vertebral column), all patients showed structural changes, 38% having Intervertebral disc prolapse, 22% having spondylosis, 20% having osteophytes, 8% with Osteosclerosis, 6% having spondylolisthesis, 5% with fractures and 1 with stenosis justifies structural changes (Hanthi Sandhi) occurs in Sandhigatha Vata (osteoarthritis). All patients had pain and restricted movements, 80% patient had swelling which justifies the symptoms of Sandhigatha Vata (osteoarthritis).
Prishtavamsha Sandhi(脊柱关节)是Cheshtavantha Prathara(活动和漂浮)类型的关节。在Prishtavamsha(脊柱)有24个关节。椎间关节是连接椎体的关节,由椎体之间的软骨关节和椎弓之间的滑膜关节组成。骨关节炎(骨性关节炎)是其中一种,它可以影响身体的所有关节。骨关节炎的主要症状是疼痛、肿胀和功能受损。在Sandhigatha Vata(骨关节炎),破坏发生在关节由于Vata聚集。但目前尚不清楚在关节中观察到的破坏类型。为了排除在Prishtavamsha(脊柱)关节中观察到的各种结构变化,正在进行这项工作。100例脊柱骨性关节炎患者中,所有患者均表现出结构改变,38%的患者椎间盘突出,22%的患者颈椎病,20%的患者骨赘,8%的患者骨硬化,6%的患者脊柱滑脱,5%的患者骨折,1例患者椎管狭窄证明脊柱骨性关节炎发生结构改变(Hanthi Sandhi)。所有患者均有疼痛和活动受限,80%患者有肿胀,这证明了骨关节炎的症状。
{"title":"Analysis of structural changes observed in Prishtavamsha Sandhigatha Vata (osteoarthritis of vertebral column)","authors":"Anju Subhash, K. N.","doi":"10.21760/jaims.5.5.18","DOIUrl":"https://doi.org/10.21760/jaims.5.5.18","url":null,"abstract":"Prishtavamsha Sandhi (joints of vertebral column) is the Cheshtavantha Prathara (movable and floating) type of joint. Twenty four joints are present in Prishtavamsha (vertebral column). Intervertebral joints are the joints which connect vertebrae to each other consists of cartilaginous joints in between the vertebral bodies and synovial joint between vertebral arches. Sandhigatha Vata (osteo arthritis) is one among the Vatavyadhi, which can affect all joints in the body. Sandhigatha Vata (osteoarthritis) will be dominated with symptoms like pain, swelling and impairment of function. In Sandhigatha Vata (osteoarthritis), destruction occurs in the joints due to aggrevated Vata. But it is not clear about the type of destruction observed in the joints. To rule out the various structural changes observed in the joints of Prishtavamsha (vertebral column) this work is being undertaken. Among 100 patients suffering from Prishtavamsha Sandhigatha Vata (osteoarthritis of vertebral column), all patients showed structural changes, 38% having Intervertebral disc prolapse, 22% having spondylosis, 20% having osteophytes, 8% with Osteosclerosis, 6% having spondylolisthesis, 5% with fractures and 1 with stenosis justifies structural changes (Hanthi Sandhi) occurs in Sandhigatha Vata (osteoarthritis). All patients had pain and restricted movements, 80% patient had swelling which justifies the symptoms of Sandhigatha Vata (osteoarthritis).","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"31 3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116818464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An experimental evaluation of the Lithotriptic Activity of Ayurvedic drug Kāśīśa Bhasma 阿育吠陀药物Kāśīśa Bhasma碎石活性的实验评价
Pub Date : 2020-10-25 DOI: 10.21760/jaims.5.5.28
Kusuma Tv, Jeevesh Kb, Chaitra Lv
Kāśīśa (Ferrous Sulphate, Fe2SO4.7H20), is among the most commonly used mineral drug in Ayurveda, and has been specifically indicated in Mutrashmari. Urolithiasis, (Mutrashmari in Ayurveda) is the third most common urinary system disorder globally with high recurrence rate. The present study is to determine the underlying mechanism of Kāśīśa Bhasma as lithotriptic drug in animal model. Ethylene glycol (0.75% v/v) induced urolithiasis model was used to study the lithotriptic activity of Kāśīśa Bhasma in Wistar albino rats. 30 rats were divided into five groups and were allocated interventions accordingly. Two trial drug groups were given single and double doses of Kāśīśa Bhasma (150mg/kg and 300mg/kg respectively), and were compared against the standard control group (Tab. Cystone 750mg/kg), administered for 14 days. Relevant biochemical assay and histopathological analysis was done and analysed. In vivo study revealed, Kāśīśa Bhasma administered at 300mg/kg b.w. was associated with better lithotriptic activity. The results showed significant reduction in calcium oxalate deposits in the kidneys, restoring the elevated values of serum Creatinine, BUN, uric acid and urine parameters like calcium, phosphate and oxalate while also maintaining optimal urine pH when compared to negative control. The lithotriptic activity of Kāśīśa Bhasma was found to be corresponding to that of standard drug Tab Cystone.
Kāśīśa(亚铁硫酸盐,Fe2SO4.7H20),是阿育吠陀最常用的矿物药物之一,在Mutrashmari中特别指出。尿石症是全球第三大常见泌尿系统疾病,复发率高。本研究旨在探讨Kāśīśa Bhasma作为碎石药物在动物模型中的作用机制。采用乙二醇(0.75% v/v)诱导尿石症模型,研究Kāśīśa Bhasma对Wistar白化大鼠的碎石作用。将30只大鼠分为5组,分别给予干预措施。两个试验组分别给予Kāśīśa Bhasma单剂量和双剂量(分别为150mg/kg和300mg/kg),并与标准对照组比较(见表2)。Cystone 750mg/kg),给药14天。进行相关生化试验和组织病理学分析。体内研究显示,Kāśīśa Bhasma剂量为300mg/kg b.w.与更好的碎石活性相关。结果显示,与阴性对照组相比,肾脏中草酸钙沉积显著减少,恢复了血清肌酐、尿素氮、尿酸和尿液参数(如钙、磷酸盐和草酸)的升高值,同时保持了最佳尿液pH值。Kāśīśa Bhasma的碎石活性与标准药物Tab Cystone相当。
{"title":"An experimental evaluation of the Lithotriptic Activity of Ayurvedic drug Kāśīśa Bhasma","authors":"Kusuma Tv, Jeevesh Kb, Chaitra Lv","doi":"10.21760/jaims.5.5.28","DOIUrl":"https://doi.org/10.21760/jaims.5.5.28","url":null,"abstract":"Kāśīśa (Ferrous Sulphate, Fe2SO4.7H20), is among the most commonly used mineral drug in Ayurveda, and has been specifically indicated in Mutrashmari. Urolithiasis, (Mutrashmari in Ayurveda) is the third most common urinary system disorder globally with high recurrence rate. The present study is to determine the underlying mechanism of Kāśīśa Bhasma as lithotriptic drug in animal model. Ethylene glycol (0.75% v/v) induced urolithiasis model was used to study the lithotriptic activity of Kāśīśa Bhasma in Wistar albino rats. 30 rats were divided into five groups and were allocated interventions accordingly. Two trial drug groups were given single and double doses of Kāśīśa Bhasma (150mg/kg and 300mg/kg respectively), and were compared against the standard control group (Tab. Cystone 750mg/kg), administered for 14 days. Relevant biochemical assay and histopathological analysis was done and analysed. In vivo study revealed, Kāśīśa Bhasma administered at 300mg/kg b.w. was associated with better lithotriptic activity. The results showed significant reduction in calcium oxalate deposits in the kidneys, restoring the elevated values of serum Creatinine, BUN, uric acid and urine parameters like calcium, phosphate and oxalate while also maintaining optimal urine pH when compared to negative control. The lithotriptic activity of Kāśīśa Bhasma was found to be corresponding to that of standard drug Tab Cystone.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130119376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutical evaluation of Haridra Khanda tablet 哈得拉汗达片的药学评价
Pub Date : 2020-10-25 DOI: 10.21760/jaims.5.5.24
Makrand A. Sonare, Manoja K. Samantaray
Haridra Khanda is unique classical formulation indicated in Udarda, Shitapitta, Kotha. (Urticarial rashes) Khanda or Granules are a comparatively unusual means of administering drugs that possess an unpleasant taste. Haridra Khanda is classical Ayurvedic medicine and available market. Keeping the issue of palatability and invention of patient friendly dosage form in mind, the efforts was made for preparation of tablet out of classical Ayurvedic formulation - Haridra Khanda. The preparation of Haridra Khanda granules were made by standard operative procedure.Binding agents were added to Haridra Khanda . Haridra Khanda was added to mass mixer to ensure homogeneity and easy mixing of all binding agents. And later this mixture was subjected to single punch tablet machine for preparation of 1000 mg tablet. All the Analytical parameters were passed by the Haridra Khanda tablets. Physician can prescribed the tablets to the patients which feel the powdered dosage uncomfortable. Depending on the Roga and Rogibala, tablets of various sizes can be punched and used clinically. This can work more efficiently in pediatric practice.
Haridra Khanda是尤达尔达、希塔皮塔、科塔等地独特的经典配方。(荨麻疹疹)Khanda或颗粒剂是一种相对不寻常的给药方式,它具有令人不快的味道。Haridra Khanda是经典的阿育吠陀药物和可用的市场。考虑到适口性问题和患者友好剂型的发明,为制备经典阿育吠陀制剂-哈里德拉汗达而做出了努力。采用标准操作程序制备了汗陀颗粒。将粘合剂添加到Haridra Khanda中。在质量混合器中加入Haridra Khanda,以确保所有粘合剂的均匀性和易于混合。再经单冲孔压片机制取1000mg片剂。所有的分析参数均通过了哈里得拉汗达片。医生可以给那些对粉状剂量感到不舒服的病人开这种片剂。根据Roga和Rogibala,各种大小的片剂可以打孔并用于临床。这可以在儿科实践中更有效地工作。
{"title":"Pharmaceutical evaluation of Haridra Khanda tablet","authors":"Makrand A. Sonare, Manoja K. Samantaray","doi":"10.21760/jaims.5.5.24","DOIUrl":"https://doi.org/10.21760/jaims.5.5.24","url":null,"abstract":"Haridra Khanda is unique classical formulation indicated in Udarda, Shitapitta, Kotha. (Urticarial rashes) Khanda or Granules are a comparatively unusual means of administering drugs that possess an unpleasant taste. Haridra Khanda is classical Ayurvedic medicine and available market. Keeping the issue of palatability and invention of patient friendly dosage form in mind, the efforts was made for preparation of tablet out of classical Ayurvedic formulation - Haridra Khanda. The preparation of Haridra Khanda granules were made by standard operative procedure.Binding agents were added to Haridra Khanda . Haridra Khanda was added to mass mixer to ensure homogeneity and easy mixing of all binding agents. And later this mixture was subjected to single punch tablet machine for preparation of 1000 mg tablet. All the Analytical parameters were passed by the Haridra Khanda tablets. Physician can prescribed the tablets to the patients which feel the powdered dosage uncomfortable. Depending on the Roga and Rogibala, tablets of various sizes can be punched and used clinically. This can work more efficiently in pediatric practice.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130247119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of Ayurveda and Integrated Medical Sciences (JAIMS)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1